The influence of Shaoyao Gancao Decoction on liver function and bile component in post-ercp patients with choledocholithiasis associated with abnormal liver function

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031508

Enrollment

Unknown

Registered

2020-04-03

Start date

2020-05-30

Completion date

Unknown

Last updated

2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

TCM treatment group:take peony and licorice decoction after surgery

control group:drink chrysanthemum and chinese wolfberry decoction after surgry

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients over the age of 18 were selected, regardless of gender; 2.Preoperative diagnosis was confirmed as choledocholithiasis with abnormal liver function, and the indications of ERCP were clear; 3.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Combined with other diseases that can lead to abnormal liver function; 2.Gastrointestinal bleeding, perforation, pancreatitis and other complications occurred after ERCP; 3.woman who is pregnant or nursing; 4.Difficulty swallowing and eating, severe cardiopulmonary and renal insufficiency, unable to tolerate surgery; 5.Allergic to institute drugs.

Design outcomes

Primary

Measure	Time frame
AST;ALT;TBil;Cholesterol concentration in bile;Total bile acid concentration in bile;	—

Secondary

Measure	Time frame
?-GT;ALP;TCM syndrome score;The recurrence rate of choledocholithiasis;	—

Countries

China

Contacts

Public ContactXiaodong Chen

Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine

948245071@qq.com+86 18117371062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026